Integrated BioPharma, Inc. (INBP)
OTCMKTS · Delayed Price · Currency is USD
0.3053
-0.0048 (-1.53%)
Oct 27, 2025, 3:58 PM EDT

Revenue by Product

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202003 - 2019
Period Ending
Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 2003 - 2019
Contract Manufacturing
48.57M
Log In
Log In
Log In
Log In
Upgrade
Contract Manufacturing Growth
0.60%
Log In
Log In
Log In
Log In
Upgrade
Other Nutraceutical Businesses
1.75M
Log In
Log In
Log In
Log In
Upgrade
Other Nutraceutical Businesses Growth
-26.97%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202003 - 2019
Period Ending
Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 2003 - 2019
United States
42.34M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-0.64%
Log In
Log In
Log In
Log In
Upgrade
International
7.97M
Log In
Log In
Log In
Log In
Upgrade
International Growth
-1.02%
Log In
Log In
Log In
Log In
Upgrade